Tag: Patient Satisfaction

Study: Chances of pregnancy after tubal ligation higher than previous estimates

Editor's Note Tubal sterilization, often considered a permanent form of contraception, has a failure rate of 3% to 5%, leading to unplanned pregnancies in some cases, UC San Francisco reported August 27. Publishing in NEJM Evidence, university researchers report that contraceptive arm implants or intrauterine devices (IUDs) may be more reliable…

Read More

By: Matt Danford
September 24, 2024
Share

Face transplant survival rates “encouraging,” global study finds

Editor's Note Nearly 20 years of data on the first 50 face transplants in the world indicate that survival rates exceed those of several solid organ transplants, according to a global study published September 18 in Jama Surgery. Conducted between 2005 and 2021, the study involved 18 transplant centers, assessed…

Read More

By: Matt Danford
September 19, 2024
Share

WHO, Joint Commission mark World Patient Safety Day

Editor's Note In partnership with the World Health Organization (WHO), The Joint Commission and The Joint Commission and Joint Commission International (JCI) invite organizations, health professionals, patients, and their advocates to recognize World Patient Safety Day Tuesday, September 17. This year’s theme is “improving diagnosis for patient safety.” This theme…

Read More

By: Matt Danford
September 16, 2024
Share

Study: Right-sized donor livers scarce for female cancer patients

Editor's Note A recent study in JAMA Surgery showed women with hepatocellular carcinoma (HCC) were 8% less likely than men to receive a liver transplant and 6% more likely to die or be removed from the waitlist, Healio reported September 9.    The study, which analyzed 31,725 adults waitlisted for…

Read More

By: Matt Danford
September 13, 2024
Share

Study: C-sections more likely for black women

Editor's Note Research shows black women are 25% more likely to undergo cesarean sections (C-sections) than white women, even when presenting similar medical histories, The New York Times reported September 10. The article focuses on a study analyzing nearly one million births across 68 New Jersey hospitals. Conducted between 2008…

Read More

By: Matt Danford
September 12, 2024
Share

CMS expands social determinants of health screening to outpatient settings

Editor's Note The Centers for Medicare & Medicaid Services (CMS) is expanding its social determinants of health (SDoH) initiatives to include outpatient settings, starting with voluntary reporting in 2025 and moving to mandatory reporting in 2026, MedLearn Publishing August 26 reports. This expansion aims to address gaps in care by…

Read More

By: Tarsilla Moura
August 29, 2024
Share

How perioperative staff can combat human trafficking—Part 1

Human trafficking (HT) is a global public health crisis and one of the fastest growing criminal enterprises that grosses hundreds of billions of dollars annually, all of which are tax-free profits made off the sale of human cargo. And yet, research shows the problem is poorly understood or recognized among…

Read More

By: Francine Bono-Neri, PhD, RN, APRN, PNP
August 28, 2024
Share

Pilot project takeoff proves promise of AI staff optimization

Perioperative leaders face mounting pressures to optimize resources, reduce costs, and improve patient outcomes. However, one challenge stands out among the rest: OR staffing shortages. According to a November/December survey conducted by LeanTaaS in collaboration with OR Manager, staff recruitment and retention is a top priority for OR leaders this…

Read More

By: Stacey Leadbeater
August 28, 2024
Share

Studies highlight success strategies for combatting handoff communication failure, care inequity

Editor's Note Recent research sheds new light on addressing two of the most pressing problems for surgical care: handoff communication failures and care bias and inequities leading to adverse—and preventable—events.   These problems are the subjects of two separate success stories in the August issue of The Joint Commission Journal…

Read More

By: Matt Danford
August 23, 2024
Share

Immunotherapy’s FDA approval expected to improve lung cancer treatment

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

By: Matt Danford
August 22, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat